+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Systemic Lupus Erythematosus Treatment Market Report 2026 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Opioid Related Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Related Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
From
From
Cell Therapy Clinical Activity and Process Automation - Product Thumbnail Image

Cell Therapy Clinical Activity and Process Automation

  • Report
  • July 2023
  • 100 Pages
  • Global
From
From
Herpes Simplex - Pipeline Insight, 2025 - Product Thumbnail Image

Herpes Simplex - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
Chronic Lower Back Pain Market Report 2026 - Product Thumbnail Image

Chronic Lower Back Pain Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Liver Cirrhosis Therapeutics Market 2024-2028 - Product Thumbnail Image

Liver Cirrhosis Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 154 Pages
  • Global
From
Pharmaceutical API Manufacturing Market Report 2026 - Product Thumbnail Image

Pharmaceutical API Manufacturing Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Loading Indicator